Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC: A Phase 1 Dose-Escalation and Dose-Expansion Study
1. 系统已在2026-02-17 17:53:05对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jtho.2025.02.003
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1556086425000620
其他信息:
出版社: Elsevier BV
作者: Baohui Han; Jie Liu; Lin Wu; Yanqiu Zhao; Wei Zhang; Bolin Chen; Jianbo He; Jianhua Shi; Yanqing Liu; Zhe Zhang; Xiugui Chen; Yusheng Wu

